Anti-20S proteasome antibodies in psoriatic arthritis

Journal of Rheumatology

Volumn 35, Issue 4, 2008, Pages 674-676

  Colmegna, Inés ^a   Sainz Jr , Bruno ^b   Citera, Gustavo ^c   Maldonado Cocco, Jose A ^c   Garry, Robert F ^b   Espinoza, Luis R ^a,d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

20S proteasome; Immunoreactivity; Proteasome antibodies; Psoriatic arthritis

Indexed keywords

20S PROTEASOME; ANTI 20S PROTEASOME ANTIBODY; ANTIBODY; PROTEASOME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; LABORATORY TEST; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 40649119860     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wolf DH, Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 2004;1695:19-31.
2. Osterloh P, Linkemann K, Tenzer S, et al. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. Proc Natl Acad Sci USA 2006;103:5042-7.
3. Colmegna I, Sainz B Jr, Garry RF, Espinoza LR. The proteasome and its implications in rheumatology. J Rheumatol 2005;32:1192-8.
4. Feist E, Dorner T, Kuckelkorn U, et al. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 1996;184:1313-8.
5. Feist E, Dorner T, Kuckelkorn U, Scheffler S, Burmester G, Kloetzel P. Diagnostic importance of anti-proteasome antibodies. Int Arch Allerg Immunol 2000;123:92-7.
6. Stoebner PE, Lavabre-Bertrand T, Henry L, et al. High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol 2005;152:948-53.
7. Wang X, Luo H, Chen H, Duguid W, Wu J. Role of proteasomes in T cell activation and proliferation. J Immunol 1998;160:788-801.
8. Feist E, Kuckelkorn U, Dorner T, et al. Autoantibodies in primary Sjogren's syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 1999;42:697-702.
9. Egerer K, Kuckelkorn U, Rudolph PE, et al. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J Rheumatol 2002;29:2045-52.
10. Arribas J, Luz Rodriguez M, Alvarez-Do Forno R, Castano JG. Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus. J Exp Med 1991;173:423-7.
11. Matsushita M, Takasaki Y, Takeuchi K, Yamada H, Matsudaira R, Hashimoto H. Autoimmune response to proteasome activator 28a in patients with connective tissue diseases. J Rheumatol 2004; 31:252-9.
12. Brychcy M, Kuckelkorn U, Hausdorf G, et al. Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28. Arthritis Rheum 2006;54:2175-83.